WEBINAR | Clinical Trials transition to CTR/CTIS
Ready to equip yourself with first-hand information from our experts? Join us in our new free webinar,
April 15, 2024
Ready to equip yourself with first-hand information from our experts? Join us in our new free webinar,
During these two interactive days, actors of the healthcare community alongside world experts in biosimilar medicines will gather and debate the evolving biosimilar medicines landscape and emerging trends. Discussion will focus on sharing good practices and setting collective aims to achieve the depth, breadth and speed of the use of biosimilar medicines as a lever to untap their transformative value.
Have a look at this Business Case where Asphalion provided a leading global pharmaceutical company with full
Seeking a regulatory ally to guarantee your company’s marketing materials comply with Spanish regulations? Achieve top-tier compliance
Harness the power of convenience with Asphalion’s scheduling tool – a streamlined way to arrange a meeting with our Regulatory and Safety experts.
Specially aimed at representatives from human trade organizations and national competent authorities
This guideline describes science and risk-based approaches for developing and maintaining analytical procedures suitable for the evaluation of the quality of drug substances and drug products. It complements ICH Q2 Validation of Analytical Procedures.
Watch Asphalion experts Carlos Domingo Palacios, Beatriz Ugalde, Adi Ickowicz, Rosa Sellabona, Álvaro Villarino, Vanesa Palau González,
Search or filter
Services
Memberships & Partnerships
Quality Management System
© Asphalion
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
